Market capitalization | HKD669.35b |
Enterprise Value | HKD630.33b |
PER (TTM) P/E ratio | 20.15 |
EV/FCF (TTM) EV/FCF | 11.48 |
EV/Sales (TTM) EV/Sales | 0.97 |
P/S ratio (TTM) P/S ratio | 1.03 |
P/B ratio (TTM) P/B ratio | 4.32 |
Dividend yield | 1.49% |
Last dividend (FY23) | HKD3.41 |
As a Free StocksGuide user, you can view scores for all 6,945 stocks worldwide.
35 Analysts have issued a BYD forecast:
35 Analysts have issued a BYD forecast:
Mar '24 |
+/-
%
|
||
Turnover | 650,733 650,733 |
22%
22%
|
|
Gross income | 151,786 151,786 |
48%
48%
|
|
EBITDA | - - |
-
|
EBIT (operating result) EBIT | 30,686 30,686 |
22%
22%
|
Net profit | 33,210 33,210 |
47%
47%
|
Figures in millions HKD.
If you wish, you can receive an e-mail every morning in time for breakfast containing all the stock news relevant to you.
BYD Co. Ltd. engages in the research, development, manufacture and sale of rechargeable batteries and photovoltaic business. It operates its business through four segments: Rechargeable Battery and Other Products; Mobile Handset Components and Assembly Service; Automobiles and Related Products; and Corporate and Others. The Rechargeable Battery and Other Products segment manufactures and sells lithium-ion and nickel batteries principally for mobile phones, electric tool, and other portable electronic instruments and new energy products. The Mobile Handset Components and Assembly Service segment consists of mobile handset components such as housings, keypads, and the provision of assembly services. The Automobiles and Related Products segment comprises of automobiles, auto-related moulds and components, automobiles leasing, after sales service, and skyrail related business. The company was founded by Chuan Fu Wang on February 10, 1995 and is headquartered in Shenzhen, China.
Head office | China |
CEO | Chuan Wang |
Employees | 703,500 |
Founded | 1995 |
Website | www.bydglobal.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.